Reckitt Investors To Test Class-Action Rules In Opioid Case
The Court of Appeal will consider on Tuesday whether shareholders in Reckitt Benckiser and drug company Indivior can pursue litigation linked to America's opioid crisis as a "representative claim" that is similar...To view the full article, register now.
Already a subscriber? Click here to view full article